0QF:FRA
Moderna Inc
180,26 €
arrow_upward
+0,09%(+0,16) 1D
6 tet, 1:56:43 m.d., GMT+2 · EUR
search
Të gjitha simbolet
| Me simbole | Çmimi | Ndrysho | % ndryshim |
|---|
insights_autoPo gjenerohen statistikat kryesore për 0QF...
Hap
184,78 €
I lartë
184,98 €
I ulët
180,26 €
Kapitalizimi i tregut
81,13 mld
Vëllimi mesatar
1,71 mijë
Vëllimi
1,06 mijë
Maksimumi 52-javor
184,98 €
Minimumi 52-javor
19,26 €
Numri i punonjësve
5 mijë
Hap
184,78 €
I lartë
184,98 €
I ulët
180,26 €
Kapitalizimi i tregut
81,13 mld
Vëllimi mesatar
1,71 mijë
Vëllimi
1,06 mijë
Maksimumi 52-javor
184,98 €
Minimumi 52-javor
19,26 €
Numri i punonjësve
5 mijë
Lajmet
Nga burimet në ueb dhe partnerët e lajmeve
FXLeaders
·
1 minutë më parë
Moderna Stock Holds Near $189 as Nasdaq-100 Entry and Cancer Data Drive Focus
Seeking Alpha
·
1 orë më parë
Novavax, Moderna cool as WHO downplays plague-related death in Russia
AD HOC NEWS
·
1 orë më parë
Nasdaq adds Moderna to Nasdaq-100 and lifts visibility for Moderna stock
The Daily Free Press
·
8 orë më parë
The ‘Edison of Medicine’: Moderna founder visits BU for Q&A event, shares encouragement, life experience
Profili
Moderna, Inc. is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA to carry instructions for proteins to produce an immune response. The company's name is derived from the terms "modified", "RNA", and "modern".
The company's commercial products are the Moderna COVID-19 vaccine sold under the brand names Spikevax and Mnexspike, a respiratory syncytial virus vaccine sold under the brand name Mresvia, and an influenza vaccine sold under the brand name Mflusiva. The company has 44 treatment and vaccine candidates, of which 37 have entered clinical trials. Candidates include possible vaccines for influenza, HIV, Epstein–Barr virus, the Nipah virus, chikungunya, human metapneumovirus, varicella zoster virus, as well as a cytomegalovirus vaccine, a Zika virus vaccine funded by the Biomedical Advanced Research and Development Authority, and three cancer vaccines.
In May 2026, Time ranked Moderna first in their list of the World's Most Impactful Companies. Wikipedia
Rreth Moderna Inc
Drejtori ekzekutivStephane Bancel
Punonjësit4,7 mijë
Themeluar mësht 2010
Selia-
Sektori-
Uebsajtimodernatx.com